
(AGENPARL) – SILVER SPRING lun 03 aprile 2023 Webinar will take an in-depth look at the draft guidance, explain the ICH Expert Working Group’s current scientific thinking on selected topics, and provide clarification on FDA’s planning on the implementation of M13A for generic drug applications.
Fonte/Source: http://www.fda.gov/drugs/news-events-human-drugs/navigating-first-ich-generic-drug-draft-guideline-m13a-bioequivalence-immediate-release-solid-oral